IAM
GBIO

Innovis Asset Management’s Generation Bio GBIO Stock Holding History

Innovis Asset Management’s Portfolio GBIO Stock Details GBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,002
Closed -$55.1K – 160
2023
Q2 		$55.1K Sell
1,002
-986
-50% -$45.2K 0.02% 162
2023
Q1 		$85.5K Sell
1,988
-19
-0.9% -$919 0.03% 161
2022
Q4 		$78.9K Buy
+2,007
New +$105K 0.04% 150

Other funds holding GBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Innovis Asset Management's GBIO Position: Q3 2023 in Review

Innovis Asset Management sold out of Generation Bio (GBIO) in Q3 2023, closing a stake of 1,002 shares — an estimated $55.1K sold.

Innovis Asset Management first reported a position in GBIO in Q4 2022 and held it in 3 quarters. The position peaked at $85.5K in Q1 2023. 75 funds tracked by Wall St. Rank hold GBIO as of Q3 2023.

  • Innovis Asset Management reported no remaining Generation Bio position as of Q3 2023 after selling out during the quarter.
  • Innovis Asset Management sold 1,002 Generation Bio shares in Q3 2023, an estimated $55.1K.
  • Innovis Asset Management first reported a position in Generation Bio in Q4 2022 and held it in 3 quarters.
  • Innovis Asset Management's Generation Bio position peaked at $85.5K in Q1 2023.
  • 75 funds tracked by Wall St. Rank held Generation Bio as of Q3 2023.

Based on Innovis Asset Management's 13F filing for Q3 2023, filed 9 Nov 2023.